JBCHEPHARMNSEJB Chemicals & Pharmaceuticals Limited· PharmaceuticalsHighNeutral
Announced Wed, 12 Nov · 18:49 IST

JB Chemicals & Pharmaceuticals Limited has submitted to  the Exchange a copy of Recommendation of the committee of Independent Director ( IDC) of the company on the open offer(as defined below) made by torrent pharmaceuticals ltd to the eligible shareholders of the company, under Regulation 26(7) of Securities and Exchange Board of India (SAST) Regulations, 2011 and subsequent amendments thereto ( SEBI (SAST) Regulations")

Open Offer TriggeredListed Co AcquisitionStrategic Transactions View source PDF

JBCHEPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

JB Chemicals & Pharmaceuticals has submitted the recommendation of its Committee of Independent Directors (IDC) regarding the open offer made by Torrent Pharmaceuticals to the eligible shareholders of the company. This filing is made under Regulation 26(7) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The IDC recommendation is a mandatory step in the open offer process, providing shareholders with an independent opinion on whether to tender their shares. The specific details of the recommendation (favourable, unfavourable, or neutral) are contained in the document submitted to the Exchange.

Likely market impact

This is a procedural step in the ongoing open offer by Torrent Pharmaceuticals. Shareholders should review the IDC's recommendation carefully before deciding whether to tender their shares in the open offer, as it represents an independent board-level view on the fairness of the offer price.